George Diaz

VP, Therapeutic Area Lead, Urea Cycle Disorders at iECURE

George Diaz, M.D., Ph.D., currently serves as VP, Therapeutic Area Lead for Urea Cycle Disorders (UCDs) at iECURE. Dr. Diaz joins the company with more than 25 years of experience in genetics and pediatrics, particularly in metabolic diseases and monogenic disorders. Most recently, he served as chief of the division of Medical Genetics and professor in the Departments of Genetics & Genomic Sciences and Pediatrics at Icahn School of Medicine at Mount Sinai in New York. Over his remarkable career at Mount Sinai, Dr. Diaz has collaborated extensively with industry partners to bring novel therapeutics to patients with UCDs and other rare genetic disorders. In addition to his roles at Mount Sinai, he has served as director of the Program for Inherited Metabolic Diseases, a nationally recognized specialty center for the evaluation and care of patients with inborn errors of metabolism. Dr. Diaz earned his B.A. in biology from Cornell University and his M.D. and Ph.D. from State University of New York Health Science Center at Brooklyn.

Links

Peers

View in org chart

Timeline

  • VP, Therapeutic Area Lead, Urea Cycle Disorders

    Current role